Using an Impella device to reverse refractory cardiac arrest and enable efficient coronary revascularisation

Area of Science:

• Cardiology
• Mechanical Circulatory Support

Background:

• Refractory cardiac arrest following acute myocardial infarction presents a critical therapeutic challenge.
• Current European Resuscitation Guidelines recommend veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as a rescue therapy.

Observation:

• A 54-year-old male experienced refractory cardiac arrest secondary to acute myocardial infarction.
• Veno-arterial extracorporeal membrane oxygenation was unavailable; mechanical chest compression and an Impella device were utilized.

Findings:

• The Impella device was initiated at 3.2 L/min, rapidly achieving optimal mean arterial pressure.
• Return of spontaneous circulation occurred within 1 minute.
• Echocardiography revealed a 40% left ventricular ejection fraction.
• Successful revascularization of the right coronary artery was performed.
• The patient was discharged on day 19 without neurological deficits, despite 62 minutes of low flow.

Implications:

• Mechanical circulatory support, such as the Impella device, may serve as a viable alternative to VA-ECMO in select refractory cardiac arrest scenarios.
• Further research and clinical data are needed to establish the role and efficacy of Impella devices in managing refractory cardiac arrest.
• This case suggests the potential of percutaneous mechanical circulatory support in improving outcomes for patients with acute myocardial infarction and cardiac arrest.